KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Inventory (2018 - 2025)

ClearPoint Neuro's Change in Inventory history spans 13 years, with the latest figure at $498000.0 for Q3 2025.

  • For Q3 2025, Change in Inventory rose 166.05% year-over-year to $498000.0; the TTM value through Sep 2025 reached -$293000.0, up 79.32%, while the annual FY2024 figure was -$743000.0, 40.37% up from the prior year.
  • Change in Inventory for Q3 2025 was $498000.0 at ClearPoint Neuro, up from -$404000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.5 million in Q3 2022 and bottomed at -$983000.0 in Q4 2023.
  • The 5-year median for Change in Inventory is $351000.0 (2021), against an average of $219052.6.
  • The largest annual shift saw Change in Inventory surged 3680.0% in 2021 before it plummeted 346.15% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $1.0 million in 2021, then grew by 6.88% to $1.1 million in 2022, then crashed by 189.12% to -$983000.0 in 2023, then surged by 68.57% to -$309000.0 in 2024, then soared by 261.17% to $498000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Change in Inventory are $498000.0 (Q3 2025), -$404000.0 (Q2 2025), and -$78000.0 (Q1 2025).